Back to Markets
Stocks● Neutral

Axel REE Targets 2026 for Caladão ISR Trials as Gallium Upside Gains Traction

Axel REE Targets 2026 for Caladão ISR Trials as Gallium Upside Gains Traction

Axel REE is targeting 2026 for trial mining at its Caladão project in Brazil, utilizing ISR technology while incorporating gallium and scandium recovery into its operational strategy.

Axel REE is accelerating development at its Caladão project in Brazil’s Lithium Valley, aiming to launch field recovery trials utilizing in-situ recovery (ISR) methods by 2026. The company is actively positioning the site as a multi-commodity asset, explicitly flagging the potential for gallium and scandium extraction alongside core mineral operations.

Focusing on ISR Efficiency

The pivot toward ISR technology marks a tactical shift aimed at lowering the capital intensity typically associated with traditional open-pit mining in the region. By targeting 2026 for trial mining, Axel REE intends to prove the viability of leaching processes in the specific geological profile of the Caladão deposit. Success here would provide a blueprint for scale, distinguishing the project from competitors currently reliant on conventional, higher-cost extraction methods.

The Gallium and Scandium Play

While lithium remains the primary anchor for interest in Brazil’s mining sector, the inclusion of gallium and scandium in the company's technical strategy addresses a specific supply-chain gap. Gallium is critical for high-frequency semiconductors and power electronics, commodities that have seen increased volatility due to export controls and domestic supply concerns in major producing nations.

"Axel REE advances Caladão ISR field trials in Brazil's Lithium Valley, flagging gallium/scandium upside; trial mining targeted for 2026."

Market Implications and Strategic Context

For traders and analysts, the Caladão timeline serves as a benchmark for the broader adoption of ISR techniques in Latin American rare earth and lithium projects. If the 2026 target is met, it could pressure the valuation models of peers still grappling with the permitting and environmental hurdles of traditional mining.

Investors should monitor the following factors as the company moves toward the trial phase:

  • Permitting Milestones: Any delay in environmental licensing for the ISR trials will likely trigger a repricing of the development timeline.
  • Technology Validation: The chemical recovery rates for gallium and scandium during the pilot phase will determine the project's long-term IRR.
  • Commodity Pricing: Exposure to gallium prices provides a hedge against potential softening in lithium carbonate markets, though liquidity for these secondary metals remains thin compared to base metals like those tracked in our crude oil profile.

What to Watch

Market participants should watch for updates on the specific leaching reagents Axel REE selects for the ISR process, as these will dictate the environmental footprint and regulatory approval speed. Furthermore, any partnerships established with gallium off-takers over the next 18 months will act as a proxy for the project's bankability. While the company is positioning itself for a 2026 operational start, technical breakthroughs in the field will be the primary catalyst for price action in the interim. The ability to demonstrate a low-cost, high-recovery process at scale is the key hurdle for any explorer trying to gain traction in a crowded market.

How this story was producedLast reviewed Apr 17, 2026

AI-drafted from named primary sources (exchange feeds, SEC filings, named news wires) and reviewed against AlphaScala editorial standards. Every price, earnings figure, and quote traces to a specific source.

Editorial Policy·Report a correction·Risk Disclaimer